Gender
|
Male
|
Male
|
Male
|
Age
|
86 years old
|
92 years old
|
84 years old
|
Comorbidity
|
Alzheimer
|
Hypertension
|
Hypertension, CKD, CVD
|
Aneurysm diameter
|
AAA 53 mm
|
AAA 56 mm
|
AAA 36 mm
|
R-CIAA 25mm
|
L-IIAA 26 mm
|
R-CIAA 56 mm
|
L-CIAA 25mm
|
Occluded EIA
| | | |
-Side
|
R
|
R
|
L
|
-Length/ Diameter
|
85 mm/8 mm
|
75 mm/9 mm
|
6 mm/7 mm
|
Recanalization
|
Bidirectional
|
Retrograde
|
Retrograde
|
IIA embolization
|
R
|
-
|
R
|
Landing site (R/ L)
|
EIA/ CIA
|
CIA/ CIA
|
EIA/ CIA
|
Device size
|
Mainbody: 28.5mm/12mm/12cm
|
Mainbody: 26mm/12mm/14cm
|
Mainbody:22mm/12mm/18cm
|
Rt leg: 12mm/14cm,
|
Rt leg: 14.5mm/14cm,
|
Rt leg: 12mm/10cm, 10mm/7cm
|
Lt leg (Endurant): 28mm/9.3cm
|
Lt leg: 18mm/11.5cm
|
Lt leg: 18mm/13.5cm
|
Complication
| | | |
-During EVAR
|
No
|
No
|
No
|
-Follow-up (CT/MR)
|
Type II Endoleak
|
Type II Endoleak
|
Type II Endoleak
|
ABI at occluded ilac site
| | | |
pre/ post- treatment
|
0.5/ 0.93
|
0.72/ 0.91
|
0.62/ 0.61
|
Rutherford classification at occluded iliac site
| | | |
Pre/ post- treatment
|
2/ 0
|
2/ 0
|
0/ 0
|
Aneurysm diameter
|
AAA 47 mm
|
AAA 52 mm
|
NA
|
(after 6 months)
|
R-CIAA 23mm
|
L-IIAA 27 mm
|
|
L-CIAA 25mm
| |